47.11

0.21% -0.10

After Hours: 46.77 -0.34 -0.72%

Rigel Pharmaceuticals (RIGL)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Rigel Pharmaceuticals stock is traded at $47.11, with a volume of 312.22K. It is down -0.21% in the last 24 hours and up +66.00% over the past month. Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Previous Close:

$47.21

Open:

$47.13

24h Volume:

312.22K

Relative Volume:

0.50

Market Cap:

$855.11M

Revenue:

$116.88M

Net Income/Loss:

$-25.09M

P/E Ratio:

-336.50

EPS:

-0.14

Net Cash Flow:

$-20.74M

1W Performance:

-7.55%

1M Performance:

+66.00%

6M Performance:

+129.36%

1Y Performance:

+77.84%

1-Day Range:

$46.76

$48.50

1-Week Range:

$43.81

$52.24

52-Week Range:

$14.63

$52.24

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Name

Rigel Pharmaceuticals

Sector

Healthcare (1131)

Industry

Biotechnology (632)

Phone

650-624-1100

Address

611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA

Employee

164

Twitter

@rigelpharma

Next Earnings Date

2024-11-07

Latest SEC Filings

RIGL's Discussions on Twitter

Compare RIGL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RIGL Rigel Pharmaceuticals	47.11	856.92M	116.88M	-25.09M	-20.74M	-0.14
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-05-25	Upgrade	Jefferies	Hold → Buy
Apr-03-23	Resumed	Piper Sandler	Neutral
Jun-09-22	Downgrade	Citigroup	Buy → Neutral
Jun-08-22	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jun-08-22	Downgrade	Piper Sandler	Overweight → Neutral
Mar-23-22	Initiated	B. Riley Securities	Neutral
Nov-09-20	Downgrade	JP Morgan	Overweight → Neutral
Nov-15-19	Resumed	Cantor Fitzgerald	Overweight
Sep-26-19	Resumed	JP Morgan	Overweight
Mar-01-19	Reiterated	Cantor Fitzgerald	Overweight
Aug-27-18	Initiated	Citigroup	Buy
May-02-18	Reiterated	Cantor Fitzgerald	Overweight
Dec-21-17	Resumed	Piper Jaffray	Overweight
Dec-15-17	Initiated	Cantor Fitzgerald	Overweight
Nov-06-17	Resumed	H.C. Wainwright	Buy
Mar-09-17	Reiterated	H.C. Wainwright	Buy
Aug-31-16	Reiterated	H.C. Wainwright	Buy
Aug-30-16	Reiterated	Piper Jaffray	Overweight
Jul-13-16	Initiated	H.C. Wainwright	Buy
Jun-13-16	Initiated	Piper Jaffray	Overweight
Apr-22-16	Upgrade	JP Morgan	Neutral → Overweight
Apr-08-13	Reiterated	Stifel	Buy
Nov-29-12	Initiated	UBS	Neutral
Nov-06-12	Reiterated	Oppenheimer	Outperform
Mar-26-12	Initiated	Canaccord Genuity	Hold
Dec-10-10	Downgrade	MP Advisors	Outperform → Market Perform

View All

Rigel Pharmaceuticals Stock (RIGL) Latest News

01:51 AM

Why pension funds invest in Rigel Pharmaceuticals Inc. (RI2) stock2025 Year in Review & Verified Stock Trade Ideas - Newser

01:51 AM

01:43 AM

Will Rigel Pharmaceuticals Inc. (RI2) stock enhance shareholder valueMarket Sentiment Report & AI Based Trade Execution Alerts - Newser

01:43 AM

04:40 AM

Is Rigel Pharmaceuticals Inc. (RI2) stock supported by free cash flowWeekly Investment Recap & AI Optimized Trading Strategy Guides - Newser

04:40 AM

Dec 03, 2025

Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? - Yahoo Finance

Dec 03, 2025

Why Rigel Pharmaceuticals Inc. (RI2) stock could break out in 2025 - Newser

Dec 03, 2025

Will Rigel Pharmaceuticals Inc. (RI2) stock outperform small cap peers2025 Market Overview & Weekly High Potential Stock Alerts - Newser

Dec 03, 2025

Dec 02, 2025

(RIGL) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

Dec 02, 2025

Is Rigel Pharmaceuticals Inc. (RI2) stock a top dividend aristocrat candidatePortfolio Performance Report & Long-Term Investment Growth Plans - Newser

Dec 02, 2025

Is Rigel Pharmaceuticals Inc. (RI2) stock a buy before new product rolloutWeekly Market Summary & Stock Market Timing Techniques - Newser

Dec 02, 2025

Can Rigel Pharmaceuticals Inc. (RI2) stock ride next bull market cycleTake Profit & Long-Term Capital Growth Strategies - Newser

Dec 02, 2025

Is Rigel Pharmaceuticals Inc. stock a buy for dividend growthMarket Performance Summary & Verified Technical Signals - Newser

Dec 02, 2025

Nov 30, 2025

What analysts say about Rigel Pharmaceuticals Inc RI2 stockVolume Analysis Techniques & Accelerated Financial Growth - earlytimes.in

Nov 30, 2025

Nov 28, 2025

Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference - Eastern Progress

Nov 28, 2025

Is Rigel Pharmaceuticals Inc. stock near bottom after decline2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn

Nov 28, 2025

Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? - sharewise.com

Nov 28, 2025

Rigel Pharmaceuticals Inc RI2 Stock Analysis and ForecastSmall Cap Stock Opportunities & Discover Your Financial Freedom Formula - earlytimes.in

Nov 28, 2025

Nov 27, 2025

If EPS Growth Is Important To You, Rigel Pharmaceuticals (NASDAQ:RIGL) Presents An Opportunity - simplywall.st

Nov 27, 2025

Nov 26, 2025